French National Database of Rare Dermatological Cancers
Recruiting
Observational Study
Adnexal Tumor of Skin
Merkel Cell Carcinoma
Advanced Basal Cell Carcinoma Requiring Systemic Treatment
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 9,000 (estimated)
- Sponsor
- University Hospital, Lille · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Merkel cell carcinoma, advanced basal cell carcinoma requiring systemic treatment, and cutaneous adnexal carcinomas are 3 types of rare skin cancers for which much remains unknown in terms of natural behavior, prognosis, treatment and outcomes.
CARADERM is a French prospective national cohort enrolling patients with either one of these 3 tumor types, whose objectives are :
* to provide epidemiol…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with histologically confirmed Merkel cell carcinoma, advanced basal cell carcinoma requiring systemic treatment, or cutaneous adnexal carcinoma
Exclusion Criteria:
* Subjects without Merkel cell carcinoma, advanced basal cell carcinoma requiring systemic treatment, …
Contacts